Thromboxane b2

Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.

Cross Reference

Introduction

To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Thromboxane b2?

Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Thromboxane b2

MeSH term MeSH ID Detail
Body Weight D001835 333 associated lipids
Lung Neoplasms D008175 171 associated lipids
Adenocarcinoma D000230 166 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Edema D004487 152 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Hemolysis D006461 131 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Inflammation D007249 119 associated lipids
Hypertension D006973 115 associated lipids
Glioma D005910 112 associated lipids
Weight Gain D015430 101 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Brain Ischemia D002545 89 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Seizures D012640 87 associated lipids
Arteriosclerosis D001161 86 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Atherosclerosis D050197 85 associated lipids
Stomach Ulcer D013276 75 associated lipids
Hyperlipidemias D006949 73 associated lipids
Carcinoma, Non-Small-Cell Lung D002289 72 associated lipids
Coronary Disease D003327 70 associated lipids
Colitis D003092 69 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Reperfusion Injury D015427 65 associated lipids
Pain D010146 64 associated lipids
Weight Loss D015431 56 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Leukemia, Myeloid D007951 52 associated lipids
Asthma D001249 52 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Thrombosis D013927 49 associated lipids
Fatty Liver D005234 48 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Metabolic Syndrome D024821 44 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Ischemic Attack, Transient D002546 42 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Hyperalgesia D006930 42 associated lipids
Arthritis D001168 41 associated lipids
Hypotension D007022 41 associated lipids
Zellweger Syndrome D015211 39 associated lipids
Diabetic Nephropathies D003928 39 associated lipids
Diabetic Retinopathy D003930 39 associated lipids
Lung Diseases D008171 37 associated lipids
Heart Failure D006333 36 associated lipids
Liver Cirrhosis, Experimental D008106 36 associated lipids
Per page 10 20 50 100 | Total 293

PubChem Associated disorders and diseases

What pathways are associated with Thromboxane b2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Thromboxane b2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Thromboxane b2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

What genes are associated with Thromboxane b2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Thromboxane b2

Download all related citations
Per page 10 20 50 100 | Total 6367
Authors Title Published Journal PubMed Link
Yue TL and Tong L [Effects of dauricine on the metabolism of arachidonic acid in rat pleural neutrophils]. 1989 Zhongguo Yao Li Xue Bao pmid:2558500
Fang YX et al. Beneficial changes in prostacyclin and thromboxane A2 induced by ginsenosides in myocardial infarction and reperfusion injury in dogs. 1986 Zhongguo Yao Li Xue Bao pmid:2954367
Zhu L et al. [Effects of sodium beta-3,4-dihydroxyphenyl lactate and beta-phenyl lactic acid on prostacycline and thromboxane A2 contents in the plasma of rabbits after coronary artery occlusion]. 1986 Zhongguo Yao Li Xue Bao pmid:2955643
Ren YJ et al. Inhibitory effects of nimodipine on platelet aggregation and thrombosis. 1998 Zhongguo Yao Li Xue Bao pmid:10374642
Shan CW et al. Inhibitory effects of procainamide on rabbit platelet aggregation and thromboxane B2 production in vitro. 1998 Zhongguo Yao Li Xue Bao pmid:10374644
Chen CX et al. Inhibitory effect of rhynchophylline on platelet aggregation and thrombosis. 1992 Zhongguo Yao Li Xue Bao pmid:1317985
Zhang P et al. [Effects of methylflavonolamine on TXA2 and PGI2 plasma levels in rabbits with myocardial infarction]. 1993 Zhongguo Yao Li Xue Bao pmid:8237408
Tan JQ et al. [Effects of trilobine on platelet aggregation, thromboxane A2, and prostacyclin formation in rats]. 1991 Zhongguo Yao Li Xue Bao pmid:1807088
Xiao D et al. Effects of quercetin on platelet and reperfusion-induced arrhythmias in rats. 1993 Zhongguo Yao Li Xue Bao pmid:8010047
Xuan B et al. Inhibitory effect of tetrahydroberberine on platelet aggregation and thrombosis. 1994 Zhongguo Yao Li Xue Bao pmid:8010106
Sun XM et al. [Effect of 2-naphthyl-3- (3,4-dimethoxy) phenyl-propenoic acid on the metabolism of arachidonic acid in rabbit platelets]. 1990 Zhongguo Yao Li Xue Bao pmid:2403015
Wang YZ et al. Reducing effect of 3,4',5-trihydroxystibene-3-beta-mono-D-glucoside on arterial thrombosis induced by vascular endothelial injury. 1995 Zhongguo Yao Li Xue Bao pmid:7597920
Li JS et al. [Change in intestinal free radical and prostaglandin metabolism in the aged rats with pneumococcus pneumonia]. 2003 Zhongguo Wei Zhong Bing Ji Jiu Yi Xue pmid:14552688
Yin M et al. [Experimental study of effects of cyclooxygenase-2 inhibitor on apoptosis of hypoxic myocardial cells in vitro]. 2006 Zhongguo Wei Zhong Bing Ji Jiu Yi Xue pmid:16647015
Sha JP et al. [Effect of the recombinant staphylokinase on pancreatic ischemia in severe acute pancreatitis of rats]. 2007 Zhongguo Wei Zhong Bing Ji Jiu Yi Xue pmid:17708840
Zhang J et al. [Isolation of resisting thrombus and arteriosclerosis compounds in leaves of Salix matsudana]. 1999 Zhong Yao Cai pmid:12575095
Xu L et al. [Effects of effective component from "qing kai ling" on endothelial cell of microvessel in MCAO rats]. 2004 Zhong Yao Cai pmid:15376390
Wei X et al. [Study of dahuangzhechong pills on anti-arterial thrombosis with the orthogonal design]. 2012 Zhong Yao Cai pmid:22734422
Li XQ et al. [Experimental study on the treatment of hypertension with combined traditional Chinese and Western medicine]. 1991 Zhong Xi Yi Jie He Za Zhi pmid:1725972
Wang ZY [Inhibitory effects of new-breviscapine on thrombosis in vivo]. 1989 Zhong Xi Yi Jie He Za Zhi pmid:2776271
Wang S and Zhu G [Effects of Codonopsis pilosulae on the synthesis of thromboxane A2 and prostacyclin]. 1990 Zhong Xi Yi Jie He Za Zhi pmid:2208415
Zhang YZ and Yan XF [Effects of nifedipine and Paeonia lactiflora on plasma TXB2 and 6-Keto-PGF1 alpha in cholesterol-fed rabbits]. 1990 Zhong Xi Yi Jie He Za Zhi pmid:2268930
Yu Z and Chen KJ [Effect of chuan-xiong granules on platelet aggregation, plasma beta-thromboglobulin, platelet factor IV, thromboxane B2 and 6-keto-prostaglandin F1 alpha in coronary disease patients]. 1987 Zhong Xi Yi Jie He Za Zhi pmid:2954711
Bao FZ and Shi G [Clinical and experimental study on the treatment of angina pectoris with kuo guan granules]. 1987 Zhong Xi Yi Jie He Za Zhi pmid:3690755
Liu Z [Effects of Ligusticum wallichii on the plasma levels of beta-thromboglobulin, platelet factor 4, thromboxane B2 and 6-keto-PGF1 alpha in rabbits under acute experimental cerebral ischemia]. 1990 Zhong Xi Yi Jie He Za Zhi pmid:2148509
Wang SR and Liao JZ [Effects of qixue injections on the function of platelets in coronary disease patients]. 1987 Zhong Xi Yi Jie He Za Zhi pmid:3594704
Xu QY and Jia BS [Relation between plasma thromboxane B2 and 6-keto-prostaglandin F1 alpha levels and traditional Chinese medicine in different types of ischemic heart disease patients]. 1987 Zhong Xi Yi Jie He Za Zhi pmid:3594705
Liang XC and Guo SS [Effect of jiang-zhi zhong-yao-pian on total cholesterol, triglyceride, TXB2, 6-keto-PGF1 alpha in hyperlipemic patients]. 1991 Zhong Xi Yi Jie He Za Zhi pmid:2054886
Dong G [Relation of pale tongue, purple tongue and TXA2-PGI2 regulation system]. 1990 Zhong Xi Yi Jie He Za Zhi pmid:2401034
Wang CB and Chang AM [Plasma thromboxane B2 changes in severe icteric hepatitis treated by traditional Chinese medicine--dispelling the pathogenic heat from blood, promoting blood circulation and administrating large doses of radix Paeoniae--a report of 6 cases]. 1985 Zhong Xi Yi Jie He Za Zhi pmid:3161645
Xu XY and Wang Q [The influence of sodium ferulate on hypotensive effect and urinary excretion of TXB2 after captopril in essential hypertensive patients]. 1991 Zhong Xi Yi Jie He Za Zhi pmid:1667512
Liu Z [Effects of Ligusticum wallichii on the plasma levels of beta-thromboglobulin, platelet factor 4, thromboxane B2 and 6-keto-PGF1 alpha in patients with acute cerebral infarction]. 1991 Zhong Xi Yi Jie He Za Zhi pmid:1840363
Huang HF and Wang M [Effects of gossypol and GnRHa on the prostaglandins contents of endometriotic cell and in situ]. 1991 Zhong Xi Yi Jie He Za Zhi pmid:1773465
Xi ZQ [Clinical application and prospect of bulbus Allii for relieving asthma]. 1991 Zhong Xi Yi Jie He Za Zhi pmid:1773477
Yang MF [Thromboxane B2 (125I) radioimmunoassay and its clinical uses]. 1988 Zhong Xi Yi Jie He Za Zhi pmid:3255548
Lin ZX et al. [Relation between malondialdehyde generation by platelets and plasma thromboxane B2 and diagnostic classification by syndrome differentiation of traditional Chinese medicine in stroke during acute stage]. 1991 Zhong Xi Yi Jie He Za Zhi pmid:1821334
Yang G et al. [Anti-angina effect of puerarin and its effect on plasma thromboxane A2 and prostacyclin]. 1990 Zhong Xi Yi Jie He Za Zhi pmid:2364466
Wang C et al. [Relation of changes in plasma TXB2 PGF1alpha and differentiation of signs and symptoms in traditional Chinese medicine in severe icteric hepatitis]. 1990 Zhong Xi Yi Jie He Za Zhi pmid:2379294
Zhao GR et al. [Clinical study on relationship between sluggishness of lung-defensive qi and levels of vasoactive intestinal polypeptide and thromboxane B2]. 2004 Zhong Xi Yi Jie He Xue Bao pmid:15383251
Ming HX et al. [Influence of single leaf Asarum himalaicum on renal function of rabbits]. 2004 Zhong Xi Yi Jie He Xue Bao pmid:15339444
Chen Z et al. [Correlation between TXB2, 6-Keto-PGF1alpha and liver metastasis in rats model with blood stasis]. 2003 Zhong Xi Yi Jie He Xue Bao pmid:15339561
He LQ et al. [Effect and mechanism of Tangshenning Recipe on micro-albuminuria in rats with early diabetic nephropathy]. 2003 Zhong Xi Yi Jie He Xue Bao pmid:15339583
Sun LQ et al. [Relationship between syndrome differentiation of traditional Chinese medicine and vascular endothelial function in patients with diabetic arterial occlusion of lower extremities]. 2007 Zhong Xi Yi Jie He Xue Bao pmid:17997934
Chen C et al. [Effects of extracts of Radix Scrophulariae on blood pressure in spontaneously hypertensive rats and the underlying mechanisms]. 2012 Zhong Xi Yi Jie He Xue Bao pmid:22979933
Ge Y et al. [Effect of ulinastatin on thromboxane Bâ‚‚ and deep vein thrombosis in elderly patients after hip joint replacement]. 2010 Zhong Nan Da Xue Xue Bao Yi Xue Ban pmid:21200097
Shi JJ and Huang LF [Effects of transcutaneous electrical acupoint stimulation of "Zusanli" (ST 36) on gastric mucosal injury in exercise stress-induced gastric ulcer rats]. 2013 Zhen Ci Yan Jiu pmid:24006661
Tang Z [Effect of moxibustion on humoral factors in the rat infected with epidemic hemorrhagic fever virus]. 1992 Zhen Ci Yan Jiu pmid:1364109
Tang Z et al. [Influence of moxibustion on TXA2 and PGI2 in plasma of rat infected epidemic hemorrhagic fever virus (EHFV)]. 1992 Zhen Ci Yan Jiu pmid:1356657
Xu N [Effect of electroacupuncture at "taixi" point on plasma thromboxane A2 and prostacyclin in the rabbit with renal ischemia]. 1993 Zhen Ci Yan Jiu pmid:7923725
Liu Z [Effects of acupuncture on lipid, TXB2, 6-keto-PGF, alpha in simple obese patients complicated with hyperlipidemia]. 1996 Zhen Ci Yan Jiu pmid:9388312